Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Journal articles

McKetin R, 1999, 'Use of RAM to monitor illicit drug use in developed countries: can rapid assessment result in a rapid response?', DRUG AND ALCOHOL REVIEW, 18, pp. 333 - 335, http://dx.doi.org/10.1080/09595239996491

McKetin R; Ward PB; Catts SV; Mattick RP; Bell JR, 1999, 'Changes in auditory selective attention and event-related potentials following oral administration of D-amphetamine in humans', Neuropsychopharmacology, 21, pp. 380 - 390

McKetin R; Solowij N, 1999, 'Event-related potential indices of auditory selective attention in dependent amphetamine users', Biological Psychiatry, pp. 1488 - 1497

McKetin R; Mattick RP, 1998, 'Attention and memory in illicit amphetamine users: Comparison with non-drug-using controls', Drug and Alcohol Dependence, pp. 181 - 184

McKetin R; Mattick RP, 1997, 'Attention and memory in illicit amphetamine users', Drug and Alcohol Dependence, pp. 235 - 242

Conference Papers

Mcketin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze PM; Carter G; Higgs P; Sinclair B; Reid D; Baker AL; Manning V; Pas NT; Thomas T; Bathish R; Raftery DK; Wrobel A; Saunders L; Arunogiri S; Cordaro F; Hill H; Hall S; Clare PJ; Mohebbi M; Berk M, 2021, 'PREDICTING REDUCTIONS IN METHAMPHETAMINE USE IN THE N-ICE TRIAL: A RANDOMISED CONTROLLED TRIAL OF N-ACETYL CYSTEINE FOR METHAMPHETAMINE DEPENDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S12 - S12, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ezard N; Dunlop AJ; Liaw W; Mcdonough M; Ali R; White J; Mcketin R; Bruno R; Carr A; Gill A; Rodgers C; Montebello M; Farrell M; Heinzerling K; Haber PS; Lubman DI; Graham R; Lintzeris N, 2021, 'COVID AND THE LIMA STUDY, A RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF LISDEXAMFETAMINE FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S12 - S13

Mcketin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze PM; Carter G; Higgs P; Sinclair B; Reid D; Baker AL; Manning V; Pas NT; Thomas T; Bathish R; Raftery DK; Wrobel A; Saunders L; Arunogiri S; Cordaro F; Hill H; Hall S; Clare PJ; Mohebbi M; Berk M, 2021, 'FINDINGS OF THE N-ICE STUDY: A RANDOMISED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF N-ACETYL CYSTEINE AS A PHARMACOTHERAPY FOR METHAMPHETAMINE DEPENDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S105 - S106

McKetin R; Shanahan M; Degenhardt L; Lee N; Baker AL; Lubman DI, 2016, 'PATTERNS OF HEALTH SERVICE UTILISATION IN A COHORT OF CHRONIC METHAMPHETAMINE USERS', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 55 - 55, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kothe A; McKetin R; Baker AL; Lee N; Ross J; Lubman DI; Mattick RP, 2016, 'PREDICTING ABSTINENCE FROM METHAMPHETAMINE USE AFTER RESIDENTIAL REHABILITATION', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 46 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500126&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mcketin R; Hickey K; Devlin C; Lawrence K, 2009, 'INTERVENTIONS FOR PSYCHOSTIMULANT USE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A76 - A76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dunlop A; Mcketin R; Salmon A; Holland R; Baker A, 2009, 'THE STIMULANT TREATMENT PROGRAM EVALUATION: CLIENT CHARACTERISTICS AND PRELIMINARY OUTCOMES', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A70 - A70, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300214&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McKetin R; Mattick RP, 1997, 'Impact of illicit amphetamine use on neuropsychological functioning', in Harris L (ed.), Problems of Drug Dependence, pp. 104 - 104, presented at Problems of Drug Dependence, 14 June 1997 - 19 June 1997

Conference Posters

Acheson L; Williams BHM; Farrell M; McKetin R; Ezard N; Siefried K, 2021, 'Pharmacological treatment for methamphetamine withdrawal: a systematic review and meta-analysis of randomised controlled trials', Virtual, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Man N; Chrzanowska A; McKetin R; Price O; Gibbs D; Bruno R; Sisson S; Dietze P; Salom C; Degenhardt L; Peacock A, 2020, 'Trends in methamphetamine availability, use, and harms in Australia', presented at The 2020 NDARC Annual Research Symposium, 05 November 2020 - 26 November 2020, https://ndarc.med.unsw.edu.au/resource/trends-methamphetamine-harms-australia

Conference Presentations

Webb P; Clay S; Degenhardt L; Dawe S; McKetin R, 2024, 'Influences of methamphetamine use on family relationships: Interviews with family members', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=5s

McKetin R; Clay S, 2024, 'We need to talk about contingency management', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=7YQqzJTbdAs&t=2652s

Siefried K; McKetin R; Bedi G; Brett J; Arunogiri S; Dunlop A; Lintzeris N; Ezard N, 2021, 'Symposium: An update on pharmacotherapy trials for substance use disorder - methamphetamine type and withdrawal in Australia', presented at The APSAD Scientific Drug and Alcohol Conference, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Siefried K; Arunogiri S; Brett J; McKetin R; Acheson LS; Knock E; Farrell M; Dunlop A; Lintzeris N; Ezard N, 2021, 'The future of pharmacotherapy clinical trials in Australia: the OLAM trial; the MOXY trial; the PSIMA trial; the TINA trial', presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Conference Abstracts

Acheson L; Gordon C; McKetin R; Brett J; Christmass M; Rodgers C; Lintzeris N; Dunlop A; Farrell M; Shoptaw S; Ezard N; Siefried K, 2024, 'OBJECTIVE AND SUBJECTIVE SLEEP DURING LISDEXAMFETAMINE TREATMENT OF ACUTE METHAMPHETAMINE WITHDRAWAL: NEW MEASUREMENT PARADIGM', in Drug and Alcohol Dependence, Elsevier, Vol. 260, pp. 110067, http://dx.doi.org/10.1016/j.drugalcdep.2023.110067

Leung J; Mekonen T; Wang XX; Arunogiri S; Degenhardt L; McKetin R, 2023, 'Methamphetamine exposure and depression—A systematic review and meta-analysis', in Drug and Alcohol Review, Vol. 42, pp. 1438 - 1449, http://dx.doi.org/10.1111/dar.13670

Williams BH; Acheson LS; Farrell M; McKetin R; Ezard N; Siefried KJ; Farrell M, 2022, 'PHARMACOLOGICAL TREATMENT FOR METHAMPHETAMINE WITHDRAWAL: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 56, pp. 208 - 209

Reilly R; McKetin R; Butt J; Smout M; Clark Y; Roe Y; Ezard N; Dunlop AJ; Conigrave KM; Quinn B; Treloar C; Gray D; Wilkes E; Fisher I; Longbottom W; Ward J, 2019, 'A NOVEL WEB-APP TO ASSIST ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE TO REDUCE OR STOP USING METHAMPHETAMINE: WE CAN DO THIS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S86 - S86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100216&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McKetin R; Leung J; Stockings E; Huo P; Foulds J; Lappin J; Cumming C; Arunogiri S; Young J; Sara G; Farrell M; Degenhardt L, 2019, 'MENTAL HEALTH CONSEQUENCES OF METHAMPHETAMINE USE: A SYSTEMATIC REVIEW AND META-ANALYSIS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S72 - S72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100181&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reilly R; Wand H; McKetin R; Ezard N; Dunlop AJ; Conigrave KM; Quinn B; Gray D; Wilkes E; Treloar C; Fisher I; Longbottom W; Ward J, 2019, 'METHODS OF DATA COLLECTION AND CHARACTERISTICS OF A SAMPLE OF METHAMPHETAMINE USERS: FINDINGS FROM THE NOVEL INTERVENTIONS TO ADDRESS METHAMPHETAMINE USE IN ABORIGINAL AND TORRES STRAIT ISLANDER COMMUNITIES SURVEY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S86 - S87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Quinn B; Ward B; Hall C; Jenkinson R; Cossar R; Agius P; Sutton K; Hickman M; McKetin R; Farrell M; Dietze P, 2019, 'SYMPOSIUM: INVESTIGATING METHAMPHETAMINE USE AND RELATED HARMS IN METROPOLITAN, REGIONAL AND RURAL VICTORIA VIA THE ONGOING PROSPECTIVE COHORT', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S19 - S20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Whetton S; Tait RJ; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Allsop S, 2018, 'HARMS TO RESIDENT ADULTS AND ADULT FAMILY MEMBERS OF A PERSON DEPENDENT ON METHAMPHETAMINE: COUNTING THE COSTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S74 - S75

Tait RJ; Allsop S; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Whetton S; Shanahan M, 2018, 'REMEDIATION AND PROPERTY VALUES: THE COSTS OF CLANDESTINE METHAMPHETAMINE MANUFACTURING IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S69 - S70

McKetin R; Gardner J; Baker AL; Dawe S; Ali R; Voce A; Leach L; Lubman DI, 2016, 'CORRELATES OF TRANSIENT VERSUS PERSISTENT PSYCHOTIC SYMPTOMS AMONG DEPENDENT METHAMPHETAMINE USERS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 54 - 54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500147&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ezard N; Dunlop AJ; Carr A; McKetin R; Ali R; White J; Bruno R; Dolan K; Clifford B; Lintzeris N, 2016, 'A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LISDEXAMFETAMINE FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE: THE LIMA STUDY PROTOCOL', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 35 - 36

Reports

McKetin R; Thapa P; Uthurralt N; Bo A; Degenhardt L; Farrell M; Mounteney J; Griffiths P; Degan T, 2023, An Overview Of The Evidence For Substance Use Interventions, NDARC, Sydney, http://dx.doi.org/10.26190/yb4b-1c31, https://ndarc.med.unsw.edu.au/resource/overview-evidence-substance-use-interventions

Man N; Sisson S; McKetin R; Chrzanowska A; Bruno R; Dietze P; Price O; Degenhardt L; Gibbs D; Salom C; Peacock A, 2022, Trends in methamphetamine use, markets and harms in Australia, 2003-2019, NDARC, Sydney, http://dx.doi.org/10.26190/ad59-k695

Karlsson A; Peacock A; McKetin R; Ezard N; Sutherland R, 2022, Crystal methamphetamine and use of commercial pipes amongst a sentinel sample of people who regularly use ecstasy and other illicit stimulants in Australia, 2021, NDARC, Sydney, http://dx.doi.org/10.26190/1th5-0a05

Vogl LE; Newton NC; Teesson M; Swift W; Karageorge A; Deans C; McKetin R; Steadman B; Jones J; Dillon P; Havard AE; Andrews G, 2012, Climate Schools: Universal computer-based programs to prevent alcohol and other drug use in adolescence, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, 321, http://ndarc.med.unsw.edu.au/resource/climate-schools-universal-computer-based-programs-prevent-alcohol-and-other-drug-use

Vogl LE; Newton NC; Teesson M; Swift W; Karageorge A; Havard A; Deans C; McKetin R; Steadman B; Dillon P; Andrews G, 2009, Climate Schools: Drug prevention programs, Prepared for Australian Government Department of Health and Ageing, Sydney

Torok M; Darke S; Kaye SS; Ross JE; McKetin R, 2008, Comparative rates of violent crime amongst methamphetamine and opioid users : victimistation and offending, National Drug Law Enforcement Research Fund (NDLERF), Hobart, Monograph Series No. 32, http://www.ndlerf.gov.au/pub/Monograph_32.pdf

Wardlaw G; Hetherington K; McKetin R, 2008, Final Report: Illicit Drug Reporting System. Consultant`s report to the Commonwealth Department of Human Services and Health, National Drug and Alcohol Research Centre, Sydney

Hetherington K; McKetin R, 2008, The contribution of cannabis use to psychotic symptoms among methamphetamine treatment entrants, National Drug and Alcohol Research Centre, Sydney, https://ndarc.med.unsw.edu.au/resource/contribution-cannabis-use-psychotic-symptoms-among-methamphetamine-treatment-entrants

Theses / Dissertations

McKetin R, 1999, Cognitive functioning and psychological morbidity among illicit amphetamine users

Preprints

Sivak L; Reilly R; Crumpen S; Treloar C; McKetin R; Butt J; Roe Y; Ezard N; Quinn B; Nagle J; Longbottom W; Warrior C; Ward J, 2024, An acceptability and feasibility study of the We Can Do This web-app in Australian primary care and residential rehabilitation settings for Aboriginal and Torres Strait Islander people who use methamphetamine (Preprint), http://dx.doi.org/10.2196/preprints.58369

McKetin R; Degan T; Saunders L; Nguyen L; Dore G; Shoptaw S; Farrell M; Degenhardt L; Kelly P; Turner A; Clare P; Dean O; Arunogiri S; Colledge-Frisby S; Koeijers J; Goodman-Meza D; Sinclair B; Reid D; Hill H; Hayllar J; Christmass M; Cordaro F; Lundin R; Liaw W; Liu D; Holyoak E; Wu BT-F; Kegan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland R; Byrne M; Zahra E; Russell S; Berk M, 2024, A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: A study protocol for the Tina Trial, http://dx.doi.org/10.21203/rs.3.rs-3984655/v1

Reilly R; McKetin R; Wand H; Butt J; Smout M; Ezard N; Conigrave K; Quinn B; Treloar C; Gray D; Dunlop A; Wilkes E; Ward J, 2019, ‘We Can Do This’: a web-based therapeutic program for reducing methamphetamine use and increasing help-seeking amongst Aboriginal and Torres Strait Islander people: Wait-list control, randomised trial protocol (Preprint), http://dx.doi.org/10.2196/preprints.14084

Hides L; Chan G; Dawe S; McKetin R; Kavanagh DJ; Young R; Teesson M; Saunders JB, Bidirectional Relationship Between Methamphetamine Use and Positive Psychotic Symptoms in Regular Methamphetamine Users: Evidence From a Prospective Cohort Study, http://dx.doi.org/10.2139/ssrn.3260803

Arunogiri S; Catchlove S; Bove E; McKetin R; Manning V; Bedi G; Lubman D, Protocol for an open label pilot study of intranasal oxytocin for methamphetamine withdrawal in women (mOXY trial), http://dx.doi.org/10.21203/rs.3.rs-4428433/v1

Newcombe DAL; de Fossard S; McKetin R; Nosa V; Parag V; Poa TR; Ramalho R; Ao BT; Sheridan J; Walters C; Walker N, Tū Whakaruruhau: The evaluation of treatment outcomes for methamphetamine dependence in Aotearoa New Zealand – study protocol for a prospective longitudinal cohort study and longitudinal qualitative study, http://dx.doi.org/10.21203/rs.3.rs-6256539/v1

Reilly R; McKetin R; Barzi F; Degan T; Ezard N; Conigrave K; Butt J; Roe Y; Wand H; Quinn B; Longbottom W; Treloar C; Dunlop A; Ward J, Web-Based Application for Reducing Methamphetamine Use Among Aboriginal and Torres Strait Islander People: Randomized Waitlist Controlled Trial (Preprint), http://dx.doi.org/10.2196/preprints.58341


Back to profile page